Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2016 1
2017 2
2018 1
2020 1
2021 5
2022 5
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.
Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Johnson MW, et al. J Psychopharmacol. 2014 Nov;28(11):983-92. doi: 10.1177/0269881114548296. Epub 2014 Sep 11. J Psychopharmacol. 2014. PMID: 25213996 Free PMC article. Clinical Trial.
To determine the safety and feasibility of psilocybin as an adjunct to tobacco smoking cessation treatment we conducted an open-label pilot study administering moderate (20 mg/70 kg) and high (30 mg/70 kg) doses of psilocybin within a structured 15-week sm …
To determine the safety and feasibility of psilocybin as an adjunct to tobacco smoking cessation treatment we conducted an ope …
Long-term follow-up of psilocybin-facilitated smoking cessation.
Johnson MW, Garcia-Romeu A, Griffiths RR. Johnson MW, et al. Am J Drug Alcohol Abuse. 2017 Jan;43(1):55-60. doi: 10.3109/00952990.2016.1170135. Epub 2016 Jul 21. Am J Drug Alcohol Abuse. 2017. PMID: 27441452 Free PMC article. Clinical Trial.
OBJECTIVES: To assess long-term effects of a psilocybin-facilitated smoking cessation program at 12 months after psilocybin administration. METHODS: The present report describes biologically verified smoking abstinence outcomes of the previous pilot s …
OBJECTIVES: To assess long-term effects of a psilocybin-facilitated smoking cessation program at 12 months after psilocybi …
Psilocybin or Nicotine Patch for Smoking Cessation: A Pilot Randomized Clinical Trial.
Johnson MW, Naudé GP, Hendricks PS, Garcia-Romeu A. Johnson MW, et al. JAMA Netw Open. 2026 Mar 2;9(3):e260972. doi: 10.1001/jamanetworkopen.2026.0972. JAMA Netw Open. 2026. PMID: 41805956 Free PMC article. Clinical Trial.
IMPORTANCE: Annual tobacco-related death estimates are 480 000 in the US and 8 million worldwide, surpassing mortality for other abused substances. Most smoking cessation interventions result in modest long-term success. OBJECTIVE: To compare prolonged smoking absti …
IMPORTANCE: Annual tobacco-related death estimates are 480 000 in the US and 8 million worldwide, surpassing mortality for other abused subs …
Psychedelics and health behaviour change.
Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL. Teixeira PJ, et al. J Psychopharmacol. 2022 Jan;36(1):12-19. doi: 10.1177/02698811211008554. Epub 2021 May 29. J Psychopharmacol. 2022. PMID: 34053342 Free PMC article. Review.
Healthful behaviours such as maintaining a balanced diet, being physically active and refraining from smoking have major impacts on the risk of developing cancer, diabetes, cardiovascular diseases and other serious conditions. ...In this article, we explore the notion that …
Healthful behaviours such as maintaining a balanced diet, being physically active and refraining from smoking have major impacts on t …
Human behavioral pharmacology of psychedelics.
Strickland JC, Johnson MW. Strickland JC, et al. Adv Pharmacol. 2022;93:105-132. doi: 10.1016/bs.apha.2021.10.003. Epub 2021 Nov 11. Adv Pharmacol. 2022. PMID: 35341564 Review.
This chapter provides an overview of the human behavioral pharmacology of psychedelics focusing on three prototypic classic psychedelics-psilocybin, lysergic acid diethylamide (LSD), and dimethyltryptamine (DMT). A brief historical overview of the classic psychedelics and …
This chapter provides an overview of the human behavioral pharmacology of psychedelics focusing on three prototypic classic psychedelics- …
Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.
Johnson MW. Johnson MW. Curr Top Behav Neurosci. 2022;56:213-227. doi: 10.1007/7854_2022_327. Curr Top Behav Neurosci. 2022. PMID: 35704271 Review.
I then review anthropological reports about ceremonial use of classic psychedelics and epidemiological studies that are consistent with anti-addiction efficacy. I review modern research using psilocybin in the treatment of alcohol use disorder and tobacco use disorder. Bot …
I then review anthropological reports about ceremonial use of classic psychedelics and epidemiological studies that are consistent with anti …
Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.
Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW. Noorani T, et al. J Psychopharmacol. 2018 Jul;32(7):756-769. doi: 10.1177/0269881118780612. Epub 2018 Jun 25. J Psychopharmacol. 2018. PMID: 29938565
BACKGROUND: Recent pilot trials suggest feasibility and potential efficacy of psychedelic-facilitated addiction treatment interventions. Fifteen participants completed a psilocybin-facilitated smoking cessation pilot study between 2009 and 2015. AIMS: The aims of th …
BACKGROUND: Recent pilot trials suggest feasibility and potential efficacy of psychedelic-facilitated addiction treatment interventions. Fif …
Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.
Garcia-Romeu A, Griffiths RR, Johnson MW. Garcia-Romeu A, et al. Curr Drug Abuse Rev. 2014;7(3):157-64. doi: 10.2174/1874473708666150107121331. Curr Drug Abuse Rev. 2014. PMID: 25563443 Free PMC article. Clinical Trial.
In an open-label pilot-study of psilocybin-facilitated smoking addiction treatment, 15 smokers received 2 or 3 doses of psilocybin in the context of cognitive behavioral therapy (CBT) for smoking cessation. Twelve of 15 participants (80%) demonstrated …
In an open-label pilot-study of psilocybin-facilitated smoking addiction treatment, 15 smokers received 2 or 3 doses of psi …
Psychedelic Identity Shift: A Critical Approach to Set And Setting.
Devenot N, Seale-Feldman A, Smith E, Noorani T, Garcia-Romeu A, Johnson MW. Devenot N, et al. Kennedy Inst Ethics J. 2022;32(4):359-399. doi: 10.1353/ken.2022.0022. Kennedy Inst Ethics J. 2022. PMID: 38588216
Based on a narrative analysis of the treatment manual and post-session experience reports from a pilot study of psilocybin-assisted treatment for tobacco smoking cessation, this article examines how therapeutic frameworks interact with the psychedelic substance in w …
Based on a narrative analysis of the treatment manual and post-session experience reports from a pilot study of psilocybin-assisted t …
An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.
Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. Johnson MW, et al. J Psychopharmacol. 2017 Jul;31(7):841-850. doi: 10.1177/0269881116684335. Epub 2017 Jan 18. J Psychopharmacol. 2017. PMID: 28095732 Free PMC article.
This retrospective cross-sectional anonymous online survey characterized 358 individuals (52 females) who reported having quit or reduced smoking after ingesting a psychedelic in a non-laboratory setting 1 year ago. On average, participants smoked 14 cigarettes/day …
This retrospective cross-sectional anonymous online survey characterized 358 individuals (52 females) who reported having quit or reduced …
14 results